Publicaciones (30) Publicaciones de Raquel Álvarez Lozano

2024

  1. Experimental structure based drug design (SBDD) applications for anti-leishmanial drugs: A paradigm shift?

    Medicinal Research Reviews, Vol. 44, Núm. 3, pp. 1055-1120

2023

  1. Frentizole, a Nontoxic Immunosuppressive Drug, and Its Analogs Display Antitumor Activity via Tubulin Inhibition

    International Journal of Molecular Sciences, Vol. 24, Núm. 24

  2. Novel amino analogs of the trimethoxyphenyl ring in potent colchicine site ligands improve solubility by the masked polar group incorporation (MPGI) strategy

    Bioorganic Chemistry, Vol. 131

  3. Nuevos antitumorales y antiparasitarios de naturaleza híbrida para la formación de nanopartículas

    IX Jornadas de investigadoras de Castilla y León

2021

  1. Implementación y virtualización de las Jornadas de Inicio de las Prácticas Tuteladas del Grado en Farmacia

    XVI Symposium Internacional sobre el Practicum y las prácticas externas. Prácticas externas virtuales versus presenciales: transformando los retos en oportunidades para la innovación: actas. Poio (Pontevedra) 7, 8 y 9 de julio de 2021

  2. Methylsulfanylpyridine based diheteroaryl isocombretastatin analogs as potent anti-proliferative agents

    European Journal of Medicinal Chemistry, Vol. 209

  3. Microtubule destabilizing sulfonamides as an alternative to taxane-based chemotherapy

    International Journal of Molecular Sciences, Vol. 22, Núm. 4, pp. 1-21

  4. New diarylsulfonamide inhibitors of Leishmania infantum amastigotes

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 16, pp. 45-64

2020

  1. Potent colchicine-site ligands with improved intrinsic solubility by replacement of the 3,4,5-trimethoxyphenyl ring with a 2-methylsulfanyl-6-methoxypyridine ring

    Bioorganic Chemistry, Vol. 98

2019

  1. Antitubulin sulfonamides: The successful combination of an established drug class and a multifaceted target

    Medicinal Research Reviews, Vol. 39, Núm. 3, pp. 775-830

  2. Design, Synthesis and Biological Evaluation of Benzodiazepines Analogues as Anti-Tubuling Agents

    FarmaJournal

  3. Diseño, síntesis y evaluación de amidas y sulfonamidas con actividad tipo colchicina contra Strongyloides venezuelensis

    XI Congreso de la Sociedad Española de Medicina Tropical y Salud Internacional (SEMTSI)

  4. The Masked Polar Group Incorporation (MPGI) Strategy in Drug Design: Effects of Nitrogen Substitutions on Combretastatin and Isocombretastatin Tubulin Inhibitors

    Molecules (Basel, Switzerland), Vol. 24, Núm. 23

2018

  1. Bioactive Heterometallic CuII-ZnII Complexes with Potential Biomedical Applications

    ACS Omega, Vol. 3, Núm. 10, pp. 13343-13353

  2. Efectividad de la atención farmacéutica en pacientes hipertesos en una oficina de farmacia de Villanueva de la Serena (Badajoz)

    Farmajournal, Vol. 3, Núm. 2, pp. 93-104

  3. Substitution at the indole 3 position yields highly potent indolecombretastatins against human tumor cells

    European Journal of Medicinal Chemistry, Vol. 158, pp. 167-183

2017

  1. Clobetasol Propionato en el tratamiento de la psoriasis en placas

    Farmajournal, Vol. 2, Núm. 1, pp. 111-120

2016

  1. Pyridine based antitumour compounds acting at the colchicine site

    Current Medicinal Chemistry, Vol. 23, Núm. 11, pp. 1100-1130

2015

  1. Exploring the size adaptability of the B ring binding zone of the colchicine site of tubulin with para -nitrogen substituted isocombretastatins

    European Journal of Medicinal Chemistry, Vol. 100, pp. 210-222

2014

  1. New ligands of the tubulin colchicine site based on X-ray structures

    Current Topics in Medicinal Chemistry, Vol. 14, Núm. 20, pp. 2231-2252